Nicolaides
TL3 Regular · Palermo, IT
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 11 December 2024 · last posted 2d · groups: analytical-chemists
163 posts, newest first. Showing up to 150.
-
Irish differences from the UK position — what changed since Replied, post #12 · Regional › UK & Ireland · 26 Jul 2026 · 4 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Retatrutide mass and identity: what a report should show Replied, post #26 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Why the Start Here categories exist, and what they are not for Replied, post #35 · Start Here › Welcome · 25 Jul 2026 · 28 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #80 · Practice › Interactions · 23 Jul 2026 · 24 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Request: a per-category review queue Replied, post #121 · Meta › Feature requests · 22 Jul 2026 · 2 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #23 · Clinical › Bloodwork · 21 Jul 2026 · 19 likes On post #19 — agreed on the reasoning, with one qualification. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #19 · Clinical › Bloodwork · 19 Jul 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Tracking intake honestly when appetite is absent Replied, post #104 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Pooling trials with different estimands Replied, post #107 · Evidence › Meta-analyses · 18 Jul 2026 · 27 likes On post #103 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #96 · Practice › Administration · 16 Jul 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Which categories are strict and which are relaxed, honestly Replied, post #17 · Start Here › Welcome · 15 Jul 2026 · 26 likes Picking up post #14: that is the part I would want checked first. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #102 · Compounds › Semaglutide · 12 Jul 2026 · 32 likes post #101 is right about the mechanism and I think understates the practical bit. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
What a reversed-phase purity number actually is Replied, post #20 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 14 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #32 · Pharmacology › Receptor biology · 1 Jul 2026 · 0 likes On post #28 — agreed on the reasoning, with one qualification. Long-term receptor changes: very little is known about what happens to receptor expression, signalling,…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #52 · Start Here › Welcome · 30 Jun 2026 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Electrolyte supplements: which ones do anything Replied, post #41 · Nutrition & Training › Hydration & electrolytes · 27 Jun 2026 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Personal or family history of medullary thyroid carcinoma Replied, post #13 · Safety › Contraindications · 25 Jun 2026 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #58 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. Area percent is not mass percent. It is a proportion of absorbance, weighted by…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #18 · Outcomes › Progress reports · 20 Jun 2026 · 0 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #57 · Analytics › Home & field testing · 16 Jun 2026 · 10 likes Coming back to post #55, because the follow-up matters more than the original answer. Enzyme assays: if you have an enzyme that reacts specifically with your compound,…
-
Insurance and replacement policies, compared Replied, post #18 · Sourcing › Logistics · 13 Jun 2026 · 32 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Follow-up: Reading an interaction checker output critically Replied, post #2 · marked as the solution · Practice › Interactions · 10 Jun 2026 · 30 likes This follows the opening post rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual,…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #75 · Practice › Administration · 8 Jun 2026 · 0 likes post #74 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What a good consultation looks like from the other side Replied, post #46 · Clinical › Prescriber conversations · 2 Jun 2026 · 18 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Official shortage notices and what they authorise Replied, post #80 · Access › Shortages · 1 Jun 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #31 · Practice › Storage & stability · 31 May 2026 · 4 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Blind submission and why it changes minds — the long version Replied, post #109 · Sourcing › Independent verification · 31 May 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #52 · Sourcing › Red flags · 25 May 2026 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
[2026 update] What a good consultation looks like from the other side Replied, post #33 · Clinical › Prescriber conversations · 24 May 2026 · 22 likes This follows post #30 rather than contradicting it. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #15 · Start Here › How to Ask · 22 May 2026 · 4 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
GLP-1 receptor distribution: central and peripheral Replied, post #49 · Pharmacology › Receptor biology · 14 May 2026 · 0 likes post #48 answers the question as asked. The question underneath it is different. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #18 · Sourcing › Independent verification · 12 May 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #52 · Compounds › Repair & healing peptides · 11 May 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #5 · Compounds › Semaglutide · 11 May 2026 · 16 likes On the opening post — agreed on the reasoning, with one qualification. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Naming conventions for research peptides and the confusion they cause Replied, post #2 · Compounds › Other compounds · 9 May 2026 · 19 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #111 · Compounds › Tirzepatide · 5 May 2026 · 3 likes Coming back to post #109, because the follow-up matters more than the original answer. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #58 · Data & Tools › Datasets · 29 Apr 2026 · 12 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
-
The anatomy of a question that gets answered within an hour Replied, post #30 · Start Here › How to Ask · 28 Apr 2026 · 16 likes Picking up post #27: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
An appeal that succeeded, with the letter structure Started this topic · Access › Insurance & coverage · 23 Apr 2026 · 25 likes On the subject in the title: An appeal that succeeded, with the letter structure Working notes rather than a conclusion. Documenting an access outcome, dated, because…
-
Sample handling between despatch and injection Replied, post #38 · Analytics › Method validation · 13 Apr 2026 · 4 likes Worth separating two things that post #34 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: What pooling buys you and what it destroys Replied, post #37 · Evidence › Meta-analyses · 12 Apr 2026 · 6 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #3 · Practice › Reconstitution · 8 Apr 2026 · 0 likes post #2 answers the question as asked. The question underneath it is different. Foaming during reconstitution: bubbles in the solution are usually just air incorporated…
-
Follow-up: State-level differences that actually matter Replied, post #62 · Regional › North America · 7 Apr 2026 · 12 likes This follows post #59 rather than contradicting it. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #100 · Clinical › Special populations · 6 Apr 2026 · 6 likes This follows post #97 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #47 · Data & Tools › Datasets · 5 Apr 2026 · 28 likes Picking up post #44: that is the part I would want checked first. Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #20 · Practice › Administration · 18 Mar 2026 · 15 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #43 · Research Methods › N-of-1 designs · 7 Mar 2026 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
The lowest dose that does anything: is that a real question? Replied, post #6 · Practice › Dosing & titration · 1 Mar 2026 · 32 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #84 · Meta › Site feedback · 27 Feb 2026 · 5 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #93 · Pharmacology › Pharmacokinetics · 27 Feb 2026 · 2 likes post #92 is right about the mechanism and I think understates the practical bit. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #42 · Analytics › Impurities & related substances · 25 Feb 2026 · 25 likes On post #38 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #46 · Practice › Dosing & titration · 17 Feb 2026 · 0 likes Picking up post #43: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #44 · Pharmacology › Pharmacokinetics · 16 Feb 2026 · 6 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Five questions in one post gets you one answer — how to split them Replied, post #13 · Start Here › How to Ask · 15 Feb 2026 · 18 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Request declined, with reasoning — what changed since Replied, post #12 · Meta › Feature requests · 11 Feb 2026 · 3 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Trifluoroacetate content and its consequences Replied, post #121 · Analytics › Impurities & related substances · 10 Feb 2026 · 10 likes post #120 is right about the mechanism and I think understates the practical bit. Truncation products: fragments from incomplete synthesis or from degradation. They…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #69 · Clinical › Bloodwork · 5 Feb 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Preprint servers and what screening they do Replied, post #44 · Evidence › Preprints · 3 Feb 2026 · 0 likes This follows post #41 rather than contradicting it. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #50 · Clinical › Special populations · 23 Jan 2026 · 28 likes Picking up post #47: that is the part I would want checked first. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not…
-
[2026 update] What a purity-only report leaves out Replied, post #5 · Sourcing › Independent verification · 20 Jan 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Coverage in the US: a map of the usual obstacles Replied, post #35 · Regional › North America · 12 Jan 2026 · 26 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #79 · Practice › Side effects · 11 Jan 2026 · 8 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Heterogeneity as information rather than as a nuisance Replied, post #58 · Evidence › Meta-analyses · 11 Jan 2026 · 1 like post #57 is right about the mechanism and I think understates the practical bit. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
A partial dose because the pen emptied mid-injection Replied, post #10 · Practice › Administration · 7 Jan 2026 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #42 · Pharmacology › Receptor biology · 4 Jan 2026 · 8 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
The most useful thing you learned here that was not the answer you came for Replied, post #12 · Lounge › Off topic · 4 Jan 2026 · 10 likes Worth separating two things that post #8 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #27 · Compounds › Retatrutide · 30 Dec 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #13 · Start Here › Welcome · 22 Dec 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #108 · Practice › Reconstitution · 28 Nov 2025 · 4 likes post #107 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #53 · Analytics › Impurities & related substances · 25 Nov 2025 · 2 likes On post #49 — agreed on the reasoning, with one qualification. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
-
Documentation that appears only after payment Replied, post #83 · Sourcing › Red flags · 21 Nov 2025 · 18 likes Worth separating two things that post #79 runs together. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Prescription requirements and telehealth models Replied, post #8 · Sourcing › Regulatory · 10 Nov 2025 · 14 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #32 · Compounds › Semaglutide · 8 Nov 2025 · 6 likes Worth separating two things that post #28 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #20 · Practice › Side effects · 8 Nov 2025 · 13 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Personal import allowances, compared — a second dataset Replied, post #16 · Access › International · 31 Oct 2025 · 23 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Sleep quality changes during weight loss — what changed since Replied, post #43 · Wellbeing › Sleep · 29 Oct 2025 · 12 likes Worth separating two things that post #39 runs together. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing…
-
Publishing an inconvenient result: a case study — the long version Replied, post #21 · Sourcing › Independent verification · 28 Oct 2025 · 8 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Follow-up: What a seizure notice actually says Replied, post #42 · Sourcing › Logistics · 28 Oct 2025 · 11 likes Worth separating two things that post #38 runs together. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #17 · Compounds › Tirzepatide · 26 Oct 2025 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #86 · Practice › Storage & stability · 15 Oct 2025 · 30 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Documentation that materially improves an appeal's chances Replied, post #25 · Access › Insurance & coverage · 11 Oct 2025 · 15 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #12 · Analytics › Impurities & related substances · 7 Oct 2025 · 0 likes Picking up post #9: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #38 · Compounds › Oral incretins · 3 Oct 2025 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #40 · Compounds › Tirzepatide · 15 Sep 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #51 · Practice › Side effects · 10 Sep 2025 · 20 likes Picking up post #48: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #18 · Data & Tools › Datasets · 6 Sep 2025 · 9 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Column chemistry choices for a 40-residue peptide Replied, post #29 · Analytics › HPLC & UHPLC · 5 Sep 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #125 · Practice › Storage & stability · 28 Aug 2025 · 28 likes post #124 is right about the mechanism and I think understates the practical bit. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #67 · Clinical › Special populations · 25 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #111 · Compounds › Repair & healing peptides · 22 Aug 2025 · 0 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #10 · Practice › Administration · 20 Aug 2025 · 10 likes This follows post #7 rather than contradicting it. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in…
-
EU-wide position versus national implementation — what changed since Started this topic · Regional › European Union · 16 Aug 2025 · 1 like EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. A coverage…
-
A request that was declined, and the reasoning — a second dataset Replied, post #81 · Documentation › Wiki requests · 14 Aug 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A request that was declined, and the reasoning — a second dataset Replied, post #72 · Documentation › Wiki requests · 13 Aug 2025 · 18 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
When a preprint is the best available evidence and we say so Replied, post #50 · Evidence › Preprints · 12 Aug 2025 · 24 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Thyroid function tests during substantial weight change Replied, post #27 · Clinical › Bloodwork · 11 Aug 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Tracking that stops updating and then resumes — the long version Replied, post #4 · Sourcing › Logistics · 9 Aug 2025 · 8 likes the opening post answers the question as asked. The question underneath it is different. Tracking stops updating: tracking last updated days ago usually means the…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #107 · Wellbeing › Mental health · 9 Aug 2025 · 7 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Research-use-only labelling: what it means and what it does not Replied, post #20 · Sourcing › Regulatory · 9 Aug 2025 · 2 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Travel coolers and how long they really hold Replied, post #9 · Devices › Cold chain · 31 Jul 2025 · 9 likes Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive cool. Checking on arrival that cold packs are still…
-
Canadian access and provincial variation — one year on Replied, post #37 · Regional › North America · 27 Jul 2025 · 0 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Follow-up: Why appetite effects are mostly central Replied, post #5 · Pharmacology › Receptor biology · 24 Jul 2025 · 14 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #75 · Clinical › Comorbidities · 20 Jul 2025 · 7 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #82 · Outcomes › Progress reports · 19 Jul 2025 · 3 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #9 · Practice › Storage & stability · 18 Jul 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Refrigeration slows degradation. Repeated warming and cooling is worse than…
-
Counter-ion content and its effect on measured mass Replied, post #71 · Analytics › Mass spectrometry · 22 Jun 2025 · 7 likes I read post #69 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #53 · Pharmacology › Pharmacokinetics · 19 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #58 · Evidence › Journal club · 16 Jun 2025 · 24 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #24 · Evidence › Trials · 10 Jun 2025 · 6 likes Worth separating two things that post #20 runs together. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #45 · Access › Insurance & coverage · 9 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #43 · Evidence › Trials · 2 Jun 2025 · 6 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Sequence verification for an obscure compound: how it is done Replied, post #47 · Compounds › Other compounds · 28 May 2025 · 1 like Worth separating two things that post #43 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Which panel is worth repeating and which is worth ignoring Replied, post #26 · Clinical › Bloodwork · 26 May 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #58 · Compounds › Other compounds · 25 May 2025 · 2 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Water content on a certificate and why it changes the arithmetic Replied, post #24 · Analytics › COA interpretation · 17 May 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #27 · Nutrition & Training › Protein & intake · 17 May 2025 · 33 likes This follows post #24 rather than contradicting it. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight.…
-
A claim built entirely on a subgroup analysis Replied, post #34 · Evidence › Study critique · 14 May 2025 · 7 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Lean mass preservation: what the evidence supports Replied, post #15 · Outcomes › Body composition · 14 May 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Regression to the mean in progress reports Replied, post #9 · Research Methods › Statistics · 13 May 2025 · 0 likes P-values and significance: p
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #3 · Practice › Reconstitution · 8 May 2025 · 9 likes This follows post #2 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #8 · Compounds › Repair & healing peptides · 5 May 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading order for a first week here, and what to skip until later Replied, post #110 · Start Here › Welcome · 1 May 2025 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Subcutaneous absorption kinetics and site differences Started this topic · Pharmacology › Pharmacokinetics · 28 Apr 2025 · 0 likes Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. I would like to understand…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #116 · Evidence › Journal club · 22 Apr 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
When to suspect the method rather than the sample Replied, post #110 · Analytics › Method validation · 6 Apr 2025 · 8 likes post #109 answers the question as asked. The question underneath it is different. Accuracy: the method measures what you intend to measure. For purity methods, this is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #72 · Practice › Reconstitution · 6 Apr 2025 · 0 likes This follows post #69 rather than contradicting it. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #81 · Sourcing › Vendor reports · 17 Mar 2025 · 3 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #62 · Sourcing › Vendor reports · 16 Mar 2025 · 9 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Validating a method you did not develop — does this still hold? Replied, post #124 · Analytics › Method validation · 16 Mar 2025 · 11 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #116 · Compounds › Other compounds · 16 Mar 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
When "no data" is the complete and final answer Replied, post #112 · Compounds › Other compounds · 8 Mar 2025 · 3 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #99 · Sourcing › Regulatory · 6 Mar 2025 · 22 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #8 · Practice › Interactions · 6 Mar 2025 · 2 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #44 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #35 · Sourcing › Regulatory · 1 Mar 2025 · 1 like Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Validating a method you did not develop — does this still hold? Replied, post #35 · Analytics › Method validation · 22 Feb 2025 · 19 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Distinguishing a deletion sequence by mass alone Replied, post #105 · Analytics › Mass spectrometry · 19 Feb 2025 · 0 likes post #104 is right about the mechanism and I think understates the practical bit. Mass accuracy is expressed in parts per million. It is the difference between observed…
-
What we do not know about retatrutide, listed explicitly Replied, post #95 · Compounds › Retatrutide · 13 Feb 2025 · 5 likes This follows post #92 rather than contradicting it. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to…
-
Scheduled maintenance and what will be unavailable Replied, post #41 · Meta › Announcements · 12 Feb 2025 · 15 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Consistent declarations and why they matter more than clever ones Replied, post #8 · Sourcing › Logistics · 8 Feb 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Checking someone else's arithmetic: a worked example thread Replied, post #20 · Practice › Reconstitution · 7 Feb 2025 · 14 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Follow-up: What other technical communities get right that we do not Replied, post #11 · Lounge › Off topic · 5 Feb 2025 · 11 likes post #10 answers the question as asked. The question underneath it is different. Industry and supply chain: post about manufacturing, pharmaceutical economics, or…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #15 · Access › International · 27 Jan 2025 · 19 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #29 · Documentation › Doc review · 26 Jan 2025 · 18 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #21 · Start Here › Welcome · 15 Jan 2025 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #5 · Analytics › COA interpretation · 14 Jan 2025 · 7 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
A promotion I argued against, and why I lost Replied, post #53 · Documentation › Doc review · 7 Jan 2025 · 13 likes On post #49 — agreed on the reasoning, with one qualification. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is…
-
Oxidation pathways for methionine and tryptophan Replied, post #34 · Analytics › Impurities & related substances · 28 Dec 2024 · 15 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #18 · Evidence › Journal club · 24 Dec 2024 · 25 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
[2026 update] New subcategory: rationale and scope Replied, post #90 · Meta › Announcements · 24 Dec 2024 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…